https://www.selleckchem.com/products/sf1670.html
Well-designed, long-term prospective studies comparing sacral neuromodulation (SNM) with other therapies such as pelvic floor muscle physiotherapy are warranted to offer the best patient-tailored treatment.No information is available on the efficacy of ferric carboxymaltose (FCM) in real-world CKD patients outside the hemodialysis setting. We prospectively followed 59 non-hemodialysis CKD patients with iron deficient anemia (IDA hemoglobin less then 12.0/ less then 13.5 g/dL in women/men and TSAT less then 20% and/or ferritin less then 1